Mortality Rate of Invasive Pulmonary Aspergillosis in Pediatric Patients without Hematologic Malignancy in a tertiary-care PICU: A Retrospective Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20260206005

Enrollment

115

Registered

2026-02-06

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive pulmonary Aspergillosis in PICU patient without hematologic cancer IPA , PICU , Pediatric , Intensive care

Interventions

Patient suspected IPA from modified ASP criteria - Proven IPA: Diagnosis is confirmed through histopathological examination or direct microscopy revealing dichotomous septate hyphae, accompanied by a

Other,Other

IPA group ,Non-IPA group

Eligibility

Sex/Gender

All

Age

1 Days to 18 Years

Inclusion criteria

Inclusion criteria: 1. Pediatric patients under 18 years old who were non hematologic and admitted to the PICU at KCMH from January 2013 to December 2023. 2.Patients had at least one mycological test such as histopathology cytology direct microscopy culture from lower respiratory tract specimens or galactomannan antigen testing in serum or bronchoalveolar lavage (BAL) 3. Patients were also identified from the hospital medical database for aspergillosis using ICD 10 code B44.

Exclusion criteria

Exclusion criteria: 1.Patinets admit PICU for bronchoalveolar lavage (BAL) only

Design outcomes

Primary

Measure	Time frame
mortality rates 30-day mortality number of deaths within 30 days	—

Secondary

Measure	Time frame
Risk factor for IPA At diagnosis of IPA Identification of predictors using multivariable analysis	—

Countries

Thailand

Contacts

Public ContactChanitta Saeliang

King Chulalongkorn Memorial Hospita

Chanittabeaubow@gmail.com0918466423

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026